Randomized controlled trial of Mindfulness-based cancer recovery versus supportive expressive group therapy for distressed survivors of breast cancer.
Study Goal
The researchers aimed to compare the efficacy of mindfulness-based cancer recovery (MBCR) and supportive-expressive group therapy (SET) in improving mood, stress symptoms, quality of life, and social support for distressed breast cancer survivors.
Results Summary
MBCR was superior to SET and the control group in reducing stress symptoms and improving quality of life and social support. Both MBCR and SET maintained healthier cortisol profiles compared to the control group.
Population
Distressed survivors of stage I to III breast cancer
Effective Dosage
18 hours of professional contact (group sessions)
Duration
Not explicitly stated, but intervention involved multiple sessions totaling 18 hours
Interactions
None mentioned
| Intervention | Direction | Endpoint | Population | Dosage | Impact | Claim # |
|---|---|---|---|---|---|---|
mindfulness-based cancer recovery (MBCR) | decrease | stress symptoms | distressed survivors of breast cancer | - | improved more over time on | #1 |
mindfulness-based cancer recovery (MBCR) | decrease | stress levels | distressed survivors of breast cancer | - | superior for improving | #2 |
mindfulness-based cancer recovery (MBCR) | increase | quality of life | distressed survivors of breast cancer | - | superior for improving | #3 |
mindfulness-based cancer recovery (MBCR) | increase | social support | distressed survivors of breast cancer | - | superior for improving | #4 |
mindfulness-based cancer recovery (MBCR) | no change | cortisol slopes | distressed survivors of breast cancer | - | maintained over time | #5 |
supportive-expressive group therapy (SET) | no change | cortisol slopes | distressed survivors of breast cancer | - | maintained over time | #6 |
1-day stress management control condition | decrease | cortisol slopes | distressed survivors of breast cancer | - | became flatter | #7 |
mindfulness-based cancer recovery (MBCR) | increase | quality of life | distressed survivors of breast cancer | - | greater improvements in | #8 |
mindfulness-based cancer recovery (MBCR) | increase | social support | distressed survivors of breast cancer | - | greater improvements in | #9 |
supportive-expressive group therapy (SET) | increase | diurnal cortisol profiles | distressed survivors of breast cancer | - | resulted in more normative | #10 |
mindfulness-based cancer recovery (MBCR) | increase | diurnal cortisol profiles | distressed survivors of breast cancer | - | resulted in more normative | #11 |
PURPOSE: To compare the efficacy of the following two empirically supported group interventions to help distressed survivors of breast cancer cope: mindfulness-based cancer recovery (MBCR) and supportive-expressive group therapy (SET). PATIENTS AND METHODS: This multisite, randomized controlled trial assigned 271 distressed survivors of stage I to III breast cancer to MBCR, SET, or a 1-day stress management control condition. MBCR focused on training in mindfulness meditation and gentle yoga, whereas SET focused on emotional expression and group support. Both intervention groups included 18 hours of professional contact. Measures were collected at baseline and after intervention by assessors blind to study condition. Primary outcome measures were mood and diurnal salivary cortisol slopes. Secondary outcomes were stress symptoms, quality of life, and social support. RESULTS: Using linear mixed-effects models, in intent-to-treat analyses, cortisol slopes were maintained over time in both SET (P = .002) and MBCR (P = .011) groups relative to the control group, whose cortisol slopes became flatter. Women in MBCR improved more over time on stress symptoms compared with women in both the SET (P = .009) and control (P = .024) groups. Per-protocol analyses showed greater improvements in the MBCR group in quality of life compared with the control group (P = .005) and in social support compared with the SET group (P = .012). CONCLUSION: In the largest trial to date, MBCR was superior for improving stress levels, quality of life and social support [CORRECTED] for distressed survivors of breast cancer. Both SET and MBCR also resulted in more normative diurnal cortisol profiles than the control condition. The clinical implications of this finding require further investigation.